Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy

被引：38

作者：

Tuccori, Marco ^{[1
]}

Focosi, Daniele ^{[2
]}

Blandizzi, Corrado ^{[1
,5
]}

Pelosini, Matteo ^{[2
]}

Montagnani, Sabrina ^{[1
,5
]}

Maggi, Fabrizio ^{[3
,4
]}

Pistello, Mauro ^{[3
,4
]}

Antonioli, Luca ^{[1
]}

Fornai, Matteo ^{[1
]}

Pepe, Pasquale ^{[6
]}

Rossi, Giuseppe ^{[6
]}

Petrini, Mario ^{[2
]}

机构：

[1] Univ Pisa, Dept Internal Med, Div Pharmacol & Chemotherapy, Pisa, Italy

[2] Univ Pisa, Div Haematol, Dept Oncol Transplantat & New Technol Med, Pisa, Italy

[3] Univ Pisa, Virol Sect, Pisa, Italy

[4] Univ Pisa, Retrovirus Ctr, Dept Expt Pathol, Pisa, Italy

[5] Tuscan Reg Ctr Pharmacovigilance, Pisa, Italy

[6] CNR, Unit Epidemiol & Biostat, Inst Clin Physiol, Pisa, Italy

来源：

ONCOLOGIST | 2010年 / 15卷 / 11期

关键词：

Rituximab; Progressive multifocal leukoencephalopathy; JCV; Monoclonal antibody; Non-Hodgkin's lymphoma; ADVERSE DRUG EVENTS; NATALIZUMAB; EFALIZUMAB; THERAPY; PROJECT; DISEASE; PML;

D O I：

10.1634/theoncologist.2010-0098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objectives. Rituximab is an anti-CD20 monoclonal antibody that promotes better treatment outcomes in patients with non-Hodgkin's lymphoma (NHL). Case series of progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab within polychemotherapy regimens have led to the introduction of a black box warning, but no risk estimation has ever been provided. Methods. We performed a retrospective, monocentric cohort study on 976 NHL patients diagnosed in 1994-2008, including 517 patients who received at least one dose of rituximab. Results. Inclusion of rituximab into standard chemotherapy regimens for NHL caused a significantly higher incidence of PML cases (rate difference, 2.2 every 1,000 patient-years; 95% confidence interval, 0.1-4.3). Interpretation. Based on this finding, clinical surveillance of PML-related symptoms is recommended in NHL patients exposed to rituximab. The Oncologist 2010;15:1214-1219

引用

页码：1214 / 1219

页数：6

共 50 条

[1] Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment [J].

Sano, Yasuteru ;

Nakano, Yuta ;

Omoto, Masatoshi ;

Takao, Masaki ;

Ikeda, Eiji ;

Oga, Atsunori ;

Nakamichi, Kazuo ;

Saijo, Masayuki ;

Maoka, Takashi ;

Sano, Hironori ;

Kawai, Motoharu ;

Kanda, Takashi .

INTERNAL MEDICINE, 2015, 54 (08) :965-970

[2] Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab [J].

Paues, Jakob ;

Vrethem, Magnus .

JOURNAL OF CLINICAL VIROLOGY, 2010, 48 (04) :291-293

[3] Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab [J].

Marco Tuccori ;

Daniele Focosi ;

Fabrizio Maggi ;

Mirco Cosottini ;

Barbara Meini ;

Fabio Lena ;

Corrado Blandizzi ;

Mario Del Tacca ;

Mario Petrini .

Annals of Hematology, 2010, 89 :519-522

[4] Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab [J].

Warsch, Sean ;

Hosein, Peter J. ;

Morris, Michele I. ;

Teomete, Uygar ;

Benveniste, Ronald ;

Chapman, Jennifer R. ;

Lossos, Izidore S. .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) :274-278

[5] How the discovery of rituximab impacted the treatment of B-cell non-Hodgkin's lymphomas [J].

Mohammed, Raihan ;

Milne, Artemis ;

Kayani, Kayani ;

Ojha, Utkarsh .

JOURNAL OF BLOOD MEDICINE, 2019, 10 :71-84

[6] Rituximab in the treatment of non-Hodgkin's lymphoma [J].

Hauptrock, Beate ;

Hess, Georg .

BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04) :619-633

[7] Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma A Case Report and Literature Review [J].

Felli, Valentina ;

Di Sibio, Alessandra ;

Anselmi, Monica ;

Gennarelli, Antonio ;

Sucapane, Patrizia ;

Splendiani, Alessandra ;

Catalucci, Alessia ;

Marini, Carmine ;

Gallucci, Massimo .

NEURORADIOLOGY JOURNAL, 2014, 27 (06) :657-664

[8] Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab [J].

Sean Warsch ;

Peter J. Hosein ;

Michele I. Morris ;

Uygar Teomete ;

Ronald Benveniste ;

Jennifer R. Chapman ;

Izidore S. Lossos .

International Journal of Hematology, 2012, 96 :274-278

[9] Treatment of indolent non-Hodgkin's Lymphomas [J].

Moreno Nogueira, J. A. ;

Casas Fernandez de Tejerina, A. ;

Moreno Rey, C. .

REVISTA CLINICA ESPANOLA, 2009, 209 (02) :82-87

[10] Treatment of aggressive non-Hodgkin's lymphomas [J].

Moreno Nogueira, J. A. ;

Ruiz Borrego, M. ;

Perez Valderrama, B. ;

Valero Azbiru, M. .

REVISTA CLINICA ESPANOLA, 2009, 209 (02) :88-92

← 1 2 3 4 5 →